Anti-Human CD30 Recombinant Antibody(Brentuximab)_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human CD30 Recombinant Antibody(Brentuximab)

Anti-Human CD30 Recombinant Antibody(Brentuximab)

产品编号

YR1614

别名

科研级 Brentuximab ( 本妥昔单抗 ), Anti-CD30 Recombinant Antibody, Research Grade Brentuximab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Catalog Number	YR1614
Alias	科研级 Brentuximab ( 本妥昔单抗 ), Anti-CD30 Recombinant Antibody, Research Grade Brentuximab
Size	1mg, 5mg
Molecular Name	Brentuximab
Molecular Weight	150 kDa
Target	CD30[Homo sapiens]
Antibody Isotype	Human IgG1
Clonity	Monoclonal
Concentration	1mg/ml
Purity	>95% as determined by SDS-PAGE
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Formulation	PBS, pH7.5
Shipping Condition	Shipped on ice packs.
Background	Brentuximab vedotin (INN, trade name Adcetris) is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL), a type of T cell non-Hodgkin lymphoma. It selectively targets tumor cells expressing the CD30 antigen, a defining marker of Hodgkin lymphoma and ALCL.
Remarks	This product is for research use only.

推荐产品

400-621-6806
18630936064（微信同号）
周一至周五 8:30-18:00
0